In-hospital mortality from healthcare-associated infection by multidrug-resistant Pseudomonas aeruginosa: a competing risks analysis of a 4-year propensity-matched cohort study in southern China
GMS Hygiene and Infection Control · 21.11.2025 · 20 (Doc68) · Doc68
DOI: 10.3205/dgkh000597 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift GMS Hygiene and Infection Control, erschienen am 21.11.2025. Verfasst von Mouqing Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Control, DongGuan SongShan Lake Tungwah Hospital, DongGuan, Guangdong Province, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
Background
Healthcare-associated infections (HAIs) caused by multidrug-resistant Pseudomonasaeruginosa (MDRPa) pose enormous challenges in healthcare. We examined the incidence and relative mortality rates of patients with MDRPa HAI compared to non-MDRPa HAI in southern China.
Methods
A hospital-wide longitudinal cohort study was conducted using prospectively collected surveillance data from 2018 to 2021. Poisson regression was applied to estimate incidence rate ratios (IRRs). Propensity-score matching and competing risks regression analysis (Fine-Gray model) were employed to estimate subdistribution hazard ratios (sHRs) for in-hospital mortality comparing MDRPa to non-MDRPa infections.
Results
Among 562 patients studied (mean age 58 years, 74% male, in-hospital mortality 13.7%), 278 (49%) had an MDRPa HAI and 284 (51%) a non-MDRPa HAI. The incidence rate of MDRPa HAIs increased over time (mean monthly IRR: 1.016, 95% CI: 1.007–1.024). No significant difference in 14-day in-hospital mortality between MDRPa and non-MDRPa HAIs were detected in the propensity-matched doubly-robust analysis (adjusted sHR: 1.07, 95% CI: 0.52–2.19). However, MDRPa HAI was associated with a lower probability of 14-day discharge alive (adjusted sHR: 0.44, 95% CI: 0.31–0.63), resulting in longer hospital stays.
Conclusions
The study provided real-world evidence of the clinical burden of MDRPa HAIs in China, highlighting their rising incidence and direct effect on prolonging hospitalisation. The findings underscore the need for antimicrobial stewardship interventions to ensure timely de-escalation and optimised antibiotic therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infection Control, DongGuan SongShan Lake Tungwah Hospital, DongGuan, Guangdong Province, China.
- Laboratory of Biostatistics, Division of Social Medicine, School of Medicine, University of Crete, Heraklion, Greece.
- Department of Science Research, and Education, DongGuan Tungwah Hospital, DongGuan, Guangdong Province, China.
- Department of Microbiology, DongGuan Tungwah Hospital, DongGuan, Guangdong Province, China.
- Department of Infection Control, DongGuan Tungwah Hospital, DongGuan, Guangdong Province, China.
- Chair of Model-based Environmental Exposure Science, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Zitieren
APA
Zhou, M., Kritsotakis, E. I., Xu, B., Guo, Z., Zeng, Y., Zhou, B., Brinks, R., & Wang, J. (2025). In-hospital mortality from healthcare-associated infection by multidrug-resistant Pseudomonas aeruginosa: a competing risks analysis of a 4-year propensity-matched cohort study in southern China. GMS Hygiene and Infection Control, 20(Doc68), Doc68. https://doi.org/10.3205/dgkh000597
Vancouver
Zhou M, Kritsotakis EI, Xu B, Guo Z, Zeng Y, Zhou B, et al. In-hospital mortality from healthcare-associated infection by multidrug-resistant Pseudomonas aeruginosa: a competing risks analysis of a 4-year propensity-matched cohort study in southern China. GMS Hygiene and Infection Control. 2025;20(Doc68):Doc68. doi:10.3205/dgkh000597
BibTeX
@article{Zhou2025,
author = {Zhou, Mouqing and Kritsotakis, Evangelos I and Xu, Baohua and Guo, Zhusheng and Zeng, Yongfeng and Zhou, Bin and Brinks, Ralph and Wang, Jiancong},
title = {In-hospital mortality from healthcare-associated infection by multidrug-resistant Pseudomonas aeruginosa: a competing risks analysis of a 4-year propensity-matched cohort study in southern China},
journal = {GMS Hygiene and Infection Control},
year = {2025},
volume = {20},
number = {Doc68},
pages = {Doc68},
doi = {10.3205/dgkh000597}
}
EUVIMED